Answers are grounded in this paper and cite their sources.
: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related death, and while transarterial chemoembolization (TACE) is standard for unresectable disease, its efficacy is hampered by drug resistance and limited immune activation; oncolytic virotherapy, though promising, suffers from rapid clearance and poor tumor targeting. To overcome these challenges, we engineered spatiotemporally programmable oncolytic virus-loaded microspheres (OVs-MS) that integrate embolization, sustained oncolysis, and immune stimulation. The positively charged microspheres were fabricated by emulsion-crosslinking and loaded with virus via electrostatic adsorption, yielding uniform spheres with high loading, sustained release, and catheter-compatible mechanical strength. In vitro, OVs-MS significantly suppressed proliferation, migration, and invasion of Hep-3B and Huh7 cells. In an orthotopic rat HCC model, transarterial OVs-MS embolization effectively occluded tumor-feeding vessels, markedly reduced tumor metabolism and volume, and induced extensive necrosis without major organ toxicity. In a mouse syngeneic model, OVs-MS prolonged intratumoral virus retention for 14 days, strongly inhibited tumor growth, and promoted apoptosis. Proteomic and functional analyses revealed that the virus inhibits the PI3K-AKT pathway. Critically, mass cytometry and multiplex immunofluorescence demonstrated that OVs-MS reshape the immune microenvironment more potently than free virus, driving CD8 + Granzyme B + effector T cell infiltration, M1 macrophage polarization, and reductions in Tregs and M2 macrophages, thereby converting an immunosuppressive milieu into an immune-active state. This spatiotemporally synergistic oncolytic virus microsphere system thus achieves potent antitumor efficacy through combined vascular occlusion, sustained virotherapy, and profound immune remodeling, offering a promising interventional-immunotherapeutic platform for unresectable HCC.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: